Methotrexate Wrong-Strength Error, Recall, and Social Media
At a busy community pharmacy, a 72-year-old woman with rheumatoid arthritis receives methotrexate 10 mg tablets instead of her usual 2.5 mg tablets because the technician selected the wrong strength from the shelf and the pharmacist verified the prescription against the label, not the original prescription. The label says 'take 4 tablets once weekly,' so she takes 40 mg weekly for three weeks. She returns with mouth ulcers, fatigue, and bruising; labs show pancytopenia. The error is discovered when a refill is entered. The manufacturer has also issued a Class II recall of the same lot for subpotency. The patient's daughter asks you to post about the error in a private Facebook group to warn others, and the store manager wants to 'make it right' by refunding the copay and giving a gift card.
1. What are your immediate clinical and professional obligations after discovering the error?
Read the worked answer
Patient safety comes first. Methotrexate 40 mg weekly with mouth ulcers, fatigue, bruising, and pancytopenia is a medical emergency; the patient needs same-day evaluation, urgent labs, and likely leucovorin or other rescue per the prescriber/emergency team. Do not merely refund the copay. Notify the prescriber, arrange emergency care, and monitor until handoff. Disclose the error to the patient and family promptly and honestly: what happened, what is being done, and what follow-up is needed. Apologize without speculation or blame. Document the disclosure, the clinical findings, the prescriber contact, and the plan. Quarantine the remaining stock and check the lot against the recall. Open an internal incident report and notify risk management. A gift card may be offered as a gesture, but it must not be conditioned on silence or used instead of disclosure.
2. What should you do about the Class II recall and the remaining stock, and how does that intersect with the dispensing error?
Read the worked answer
A Class II recall means exposure may cause temporary or medically reversible harm, so remove the lot from active stock immediately, quarantine it, and follow the recall notice's instructions for return or destruction. Document the quantity on hand, the lot, and the action taken. Check whether this patient received the recalled lot; if so, include that in the prescriber and patient communication. For non-controlled drugs, return via the recall process or reverse distributor as directed; do not return dispensed product to stock. The recall does not explain the wrong-strength error, but it adds another reason to verify the product. Report the recall internally and, if the recall notice requires customer notification, follow the manufacturer's instructions. Do not destroy records. Retain the recall documentation.
3. How should you handle the daughter's social media request and the manager's refund/gift card proposal under HIPAA and Maryland ethics rules?
Read the worked answer
Do not post about the patient in any Facebook group, even a private one. HIPAA protects identifiable health information, and the daughter is not authorized to consent for the patient unless the patient has given permission. A general post without identifiers is still risky because the combination of details could identify the patient. If the patient authorizes disclosure, you still do not need to post; use internal QI and, if appropriate, a de-identified educational summary approved by risk management. The store manager may refund the copay as customer service, but a gift card must not be framed as compensation for silence or as an admission. Document the refund separately from the clinical disclosure. If the error caused serious harm, consult risk management about any mandatory Board or agency reporting; do not let social media pressure drive the reporting decision.